Silexion Therapeutics (SLXN) Institutional Ownership $0.86 +0.02 (+2.57%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$0.87 +0.00 (+0.28%) As of 07/25/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Silexion Therapeutics (NASDAQ:SLXN)CurrentInstitutional OwnershipPercentage10.95%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$4.86MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.82M Get SLXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Silexion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Silexion Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/8/2025 Meyer Handelman Co.32,967$36K0.0%N/A0.392% 1/29/2025 Wildcat Capital Management LLC113,428$228K0.1%-88.9%7.089% 11/9/2024 Wildcat Capital Management LLC1,020,852$536K0.3%N/A7.381% (Data available from 1/1/2016 forward) SLXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Silexion Therapeutics shares: Wildcat Capital Management LLC ($228K), Meyer Handelman Co. ($36K).Learn more on Silexion Therapeutics' institutional investors. What percentage of Silexion Therapeutics' stock is owned by institutional investors? 10.95% of Silexion Therapeutics' stock is owned by institutional investors. Learn more on SLXN's institutional investor holdings. Which institutional investors have been buying Silexion Therapeutics' stock? The following institutional investors have purchased Silexion Therapeutics' stock in the last 24 months: Wildcat Capital Management LLC ($1.02M), and Meyer Handelman Co. ($32.97K). How much institutional buying is happening at Silexion Therapeutics? Institutional investors have bought a total of 1,053,819 shares in the last 24 months. This purchase volume represents approximately $4.86M in transactions. Which of Silexion Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Silexion Therapeutics stock in the last 24 months: Wildcat Capital Management LLC ($907.42K). How much institutional selling is happening at Silexion Therapeutics? Institutional investors have sold a total of 907,424 shares in the last 24 months. This volume of shares sold represents approximately $1.82M in transactions. Related Companies SCYNEXIS Major Shareholders Enlivex Therapeutics Major Shareholders NeuroSense Therapeutics Major Shareholders Generation Bio Major Shareholders NanoViricides Major Shareholders ALX Oncology Major Shareholders Q32 Bio Major Shareholders FibroBiologics Major Shareholders Clearside Biomedical Major Shareholders Rani Therapeutics Major Shareholders This page (NASDAQ:SLXN) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silexion Therapeutics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Silexion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLXN Stock Alerts